The results of early trials of the Johnson & Johnson COVID-19 vaccine are promising, and if Phase 3 trials are successful, we could soon have another tool in our pandemic toolbox to use against the virus.
Phase 1 and 2 trials of the vaccine showed it safely and effectively generated an immune response to SARS-CoV-2, the virus that causes COVID-19. That immune response was generated by a single dose, which would give it a distinct advantage over two-dose vaccines.
According to the New York Post, more than 90% of the 805 study volunteers developed neutralizing antibodies offering protection against COVID-19 in 29 days after getting a single dose of the vaccine. These antibodies remained active for 71 days after inoculation in the participants aged 18 to 55, according to the Post.
The next step, Phase 3 trials, will determine if the vaccine can safely and effectively protect a larger, randomly selected group people against infection or symptoms of the coronavirus. If effective, the new vaccine will be submitted for approval by the U.S. Food and Drug Administration (FDA).
Read more at NEWSMAX.
{Matzav.com}
Can someone with a bit of a brain explain why anyone would take the shot when Covid has been proven to be a political virus? (You don’t really have to be a rocket scientist to see that no doctor ever came on air throughout the year regarding the situation of Covid.)
On this site? Are you kidding? You expect a logical answer from sheep who believe in hoaxes and nonsense and are still wearing masks?